How to Help Your Patients Find Nimodipine in Stock: A Provider's Guide

When your aneurysmal subarachnoid hemorrhage (aSAH) patient is discharged from the hospital, one of the most critical continuity-of-care tasks is ensuring they can reliably fill and take their nimodipine prescription. The standard 21-day course at 60 mg every 4 hours is a Level I evidence-based recommendation — yet many patients are discharged without a confirmed pharmacy source for nimodipine.

With Nymalize oral solution in FDA shortage and generic nimodipine capsules stocked sporadically at retail pharmacies, providers need a practical playbook for helping patients navigate this gap. This guide provides that playbook.

Step 1: Address Formulation Before Discharge

The first decision point is which nimodipine formulation the patient will use after discharge. There are two options:

• Generic nimodipine 30 mg capsules: Preferred for patients who can swallow. More widely available at retail pharmacies. Much easier for patients and caregivers to manage at home.
• Nymalize 6 mg/mL oral solution (prefilled syringe): For patients who cannot swallow or require tube administration. Currently in FDA shortage, requiring advance pharmacy coordination.

Whenever clinically appropriate, switching patients who were on inpatient IV or liquid nimodipine to oral capsules at discharge simplifies outpatient supply dramatically. Confirm swallowing ability with speech therapy prior to discharge if there is any uncertainty.

Step 2: Verify Pharmacy Stock Before Writing the Discharge Prescription

Do not assume the patient's regular pharmacy carries nimodipine. Because it is a low-volume medication tied to a rare indication, many retail pharmacies — even major chains — do not stock it routinely. A patient sent home without a verified pharmacy source is at risk of a treatment gap.

Options for verifying and securing outpatient supply:

• Hospital outpatient pharmacy: Dispense the remaining days of nimodipine directly from your institution's outpatient pharmacy. Most hospital pharmacies stock nimodipine inpatient and can transfer supply to the outpatient setting.
• Specialty pharmacy referral: Specialty pharmacies often stock low-volume, high-acuity medications. Establish a relationship with a local specialty pharmacy that can reliably supply nimodipine for discharged SAH patients.
• Call major chains ahead of discharge: Have your nursing or case management team call CVS, Walgreens, Walmart, and local independent pharmacies to confirm stock before writing the discharge prescription.

Step 3: Refer Patients to medfinder for Pharmacy Search Support

If your discharge planning team doesn't have time to call pharmacies on behalf of each patient, medfinder can fill this gap. medfinder is a service where patients enter their medication, dosage, and location, and the service calls pharmacies near them to check availability. Results are texted directly to the patient or caregiver.

For discharged SAH patients — many of whom are medically fragile, may have cognitive limitations from the hemorrhage, and may be dependent on a caregiver — having a service that does the pharmacy calling for them is a meaningful support. Consider including medfinder in your discharge instructions as a pharmacy-search resource.

Step 4: Educate Patients and Caregivers on Why Continuity Matters

Many patients and caregivers don't fully understand why nimodipine must be taken every 4 hours — even through the night — or what the consequences of missing doses might be. Clear discharge education should include:

• Why nimodipine is used (prevents vasospasm that can cause stroke after brain bleed)
• The exact schedule: 60 mg every 4 hours for the full remaining days of the 21-day course
• To take on an empty stomach and avoid grapefruit
• To call the neurology team immediately if they cannot find the medication — do NOT stop without provider guidance
• To watch for blood pressure drops (dizziness, lightheadedness) and report to their provider

Step 5: Confirm Insurance Coverage and Address Cost Barriers

Generic nimodipine capsules are covered by most Medicare Part D and commercial insurance plans. However, out-of-pocket costs can be significant at retail price ($439–$1,555 per 30 capsules without discount). Patients without insurance or with high copays should be directed to:

• GoodRx or SingleCare coupons — can reduce generic capsule cost to as low as $28–$68 per 30 capsules
• Arbor Pharmaceuticals patient assistance programs for Nymalize
• NeedyMeds.org for additional patient assistance resources

Also see our companion post: Nimodipine Shortage: What Providers Need to Know in 2026 for current FDA and ASHP shortage status updates.